ResearcherYamaguchi UniversityActive in the last 2 years
Koji Tamada
Matched on ORCID iD 0000-0002-3098-2565; OpenAlex author ID A5002617255. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 16
2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper
Papers 3
- Therapeutic Efficacy of IL7/CCL19-Expressing CAR-T Cells in Intractable Solid Tumor Models of Glioblastoma and Pancreatic Cancer. Last author DOI 10.1158/2767-9764.crc-24-0226↗
- High expression of olfactomedin-4 is correlated with chemoresistance and poor prognosis in pancreatic cancer. Co-author DOI 10.1371/journal.pone.0226707↗
- A stem cell medium containing neural stimulating factor induces a pancreatic cancer stem-like cell-enriched population. Co-author DOI 10.3892/ijo.2014.2603↗
Closest collaborators
The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Masao Nakajima · 1 shared paper, 2024 · strength 0.23
- Hiroaki Nagano · 1 shared paper, 2024 · strength 0.23
- Keisuke Ohta · 1 shared paper, 2024 · strength 0.23
- Erica Yada · 1 shared paper, 2020 · strength 0.08
- Satoshi Wada · 1 shared paper, 2020 · strength 0.08
- Tetsuro Sasada · 1 shared paper, 2020 · strength 0.08
- Yutaro Kubota · 1 shared paper, 2020 · strength 0.08
- Takehiko Yokobori · 1 shared paper, 2020 · strength 0.08
- Ryotaro Ohkuma · 1 shared paper, 2020 · strength 0.08
- Tomoko Norose · 1 shared paper, 2020 · strength 0.08
- Masaaki Oka · 1 shared paper, 2014 · strength 0.03
- Yusaku Watanabe · 1 shared paper, 2014 · strength 0.03
- Yoshitaro Shindo · 1 shared paper, 2014 · strength 0.03
- Nobuaki Suzuki · 1 shared paper, 2014 · strength 0.03
- Ryouichi Tsunedomi · 1 shared paper, 2014 · strength 0.03
- Hideyuki Saya · 1 shared paper, 2014 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.